This page in English
Laddar profil information


EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia
Young E, Noerenberg D, Mansouri L, Ljungström V, Frick M, Sutton La, et al
Leukemia 2017;31(7):1547-1554

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres
Navrkalova V, Young E, Baliakas P, Radova L, Sutton La, Plevova K, et al
Haematologica 2016;101(9):e369-73

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma
Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, et al
BLOOD 2016;128(23):2666-2670

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
Parker H, Rose-zerilli Mj, Larrayoz M, Clifford R, Edelmann J, Blakemore S, et al
Leukemia 2016;30(11):2179-2186

Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2
Bhoi S, Ljungström V, Baliakas P, Mattsson M, Smedby Ke, Juliusson G, et al
Epigenetics 2016;11(6):449-55

Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic Leukemia
Pandzic T, Larsson J, He Lq, Kundu S, Ban K, Akhtar-ali M, et al
CLINICAL CANCER RESEARCH 2016;22(24):6217-6227

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
Ljungström V, Cortese D, Young E, Pandzic T, Mansouri L, Plevova K, et al
Blood 2016;127(8):1007-16

Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing: Experience from Pheochromocytoma
Crona J, Ljungstrom V, Welin S, Walz Mk, Hellman P, Bjorklund P
PLOS ONE 2015;10(7):e0133210-

Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
Mansouri L, Sutton La, Ljungström V, Bondza S, Arngården L, Bhoi S, et al
The Journal of experimental medicine 2015;212(6):833-43

Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing
Parry M, Rose-zerilli Mj, Ljungström V, Gibson J, Wang J, Walewska R, et al
Clinical cancer research : an official journal of the American Association for Cancer Research 2015;21(18):4174-4183

HaloPlex Targeted Resequencing for Mutation Detection in Clinical Formalin-Fixed, Paraffin-Embedded Tumor Samples
Moens Lnj, Falk-sorqvist E, Ljungstrom V, Mattsson J, Sundstrom M, La Fleur L, et al

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
Malcovati L, Karimi M, Papaemmanuil E, Ambaglio I, Jädersten M, Jansson M, et al
Blood 2015;126(2):233-41

Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting
Sutton La, Ljungström V, Mansouri L, Young E, Cortese D, Navrkalova V, et al
Haematologica 2015;100(3):370-6

Tumor Vessel Up-Regulation of INSR Revealed by Single-Cell Expression Analysis of the Tyrosine Kinome and Phosphatome in Human Cancers
Kiflemariam S, Ljungstrom V, Ponten F, Sjoblom T

Feasibility of targeted next-generation sequencing of the TP53 and ATM genes in chronic lymphocytic leukemia
Mansouri L, Sutton La, Ljungström V, Sörqvist Ef, Gunnarsson R, Smedby Ke, et al
Leukemia 2014;28(3):694-6

Visa alla publikationer